R. Barrangou, C. Fremaux, H. Deveau, M. Richards, P. Boyaval et al., CRISPR provides acquired resistance against viruses in prokaryotes, Science, vol.315, pp.1709-1712, 2007.

B. L. Bassler and R. Losick, Bacterially speaking, Cell, vol.125, pp.237-246, 2006.

E. B. Breidenstein, C. De-la-fuente-núñez, and R. E. Hancock, Pseudomonas aeruginosa: all roads lead to resistance, Trends Microbiol, vol.19, pp.419-426, 2011.

B. K. Chan, M. Sistrom, J. E. Wertz, K. E. Kortright, D. Narayan et al., Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa, Sci. Rep, vol.6, p.26717, 2016.

E. Chapman-mcquiston and X. L. Wu, stochastic receptor expression allows sensitive bacteria to evade phage attack. part I: experiments, Biophys. J, vol.94, pp.4525-4536, 2008.

J. Chessa, I. Petrescu, M. Bentahir, J. Van-beeumen, and C. Gerday, Purification, physico-chemical characterization and sequence of a heat labile alkaline metalloprotease isolated from a psychrophilic Pseudomonas species, Biochim. Biophys, vol.1479, pp.265-274, 2000.

A. Diop, S. Khelaifia, N. Armstrong, N. Labas, P. Fournier et al., Microbial culturomics unravels the halophilic microbiota repertoire of table salt: description of Gracilibacillus massiliensis sp, nov. Microb. Ecol. Health Dis, vol.27, p.32049, 2016.

P. Domingo-calap, P. Georgel, and S. Bahram, Back to the future: bacteriophages as promising therapeutic tools, HLA, vol.87, pp.133-140, 2016.

J. A. Driscoll, S. L. Brody, and M. H. Kollef, The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections, Drugs, vol.67, pp.351-368, 2007.

B. M. Ertugrul, O. Oncul, N. Tulek, A. Willke, S. Sacar et al., A prospective, multi-center study: factors related to the management of diabetic foot infections, Eur. J. Clin. Microbiol. Infect. Dis, vol.31, pp.2345-2352, 2012.

, European Society of Clinical Microbiology and Infectious Diseases, 2018.

L. Fenner, H. Richet, D. Raoult, L. Papazian, C. Martin et al., Are clinical isolates of Pseudomonas aeruginosa more virulent than hospital environmental isolates in amebal co-culture test?, Crit. Care Med, vol.34, pp.823-828, 2006.

G. Greub and D. Raoult, Microorganisms resistant to free-living amoebae, Clin. Microbiol. Rev, vol.17, pp.413-433, 2004.

A. Guendouze, L. Plener, J. Bzdrenga, P. Jacquet, B. Rémy et al., Effect of quorum quenching lactonase in clinical isolates of Pseudomonas aeruginosa and comparison with quorum sensing inhibitors, Front. Microbiol, vol.8, p.277, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01489514

P. Gupta, S. Chhibber, and K. Harjai, Efficacy of purified lactonase and ciprofloxacin in preventing systemic spread of Pseudomonas aeruginosa in murine burn wound model, Burns, vol.41, pp.153-162, 2015.

J. Hiblot, G. Gotthard, E. Chabriere, E. , and M. , Characterisation of the organophosphate hydrolase catalytic activity of SsoPox, Sci. Rep, vol.2, p.779, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01772542

J. Hiblot, G. Gotthard, M. Elias, C. , and E. , Differential active site loop conformations mediate promiscuous activities in the lactonase SsoPox, PLoS One, vol.8, p.75272, 2013.

Z. Hosseinidoust, T. G. Van-de-ven, and N. Tufenkji, Evolution of Pseudomonas aeruginosa virulence as a result of phage predation, Appl. Environ. Microbiol, vol.79, pp.6110-6116, 2013.

N. M. Høyland-kroghsbo, J. Paczkowski, S. Mukherjee, J. Broniewski, E. Westra et al., Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system, Proc. Natl. Acad. Sci. U.S.A, vol.114, pp.131-135, 2017.

S. Hraiech, J. Hiblot, J. Lafleur, H. Lepidi, L. Papazian et al., Inhaled lactonase reduces Pseudomonas aeruginosa quorum sensing and mortality in rat pneumonia, PLoS One, vol.9, p.107125, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01243714

P. Jault, T. Leclerc, S. Jennes, J. P. Pirnay, Y. Que et al., Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial, Lancet Infect. Dis, vol.19, issue.18, pp.30482-30483, 2018.

A. Kakasis and G. Panitsa, Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review, Int. J. Antimicrob. Agents, vol.53, pp.16-21, 2018.

A. M. Kropinski, A. Mazzocco, T. E. Waddell, E. Lingohr, J. et al., Enumeration of bacteriophages by double agar overlay plaque assay, Methods Mol. Biol, vol.501, pp.69-76, 2009.

E. Kutter, D. De-vos, G. Gvasalia, Z. Alavidze, L. Gogokhia et al., Phage therapy in clinical practice: treatment of human infections, Curr. Pharm. Biotechnol, vol.11, pp.69-86, 2010.

S. J. Labrie, J. E. Samson, and S. Moineau, Bacteriophage resistance mechanisms, Nat. Rev. Microbiol, vol.8, pp.317-327, 2010.

B. A. Lipsky, Diabetic foot infections: current treatment and delaying the 'post-antibiotic era, Diabetes Metab. Res. Rev, vol.32, pp.246-253, 2016.

C. Loc-carrillo, A. , and S. T. , Pros and cons of phage therapy, Bacteriophage, vol.1, pp.111-114, 2011.

C. Matz, A. M. Moreno, M. Alhede, M. Manefield, A. R. Hauser et al., Pseudomonas aeruginosa uses type III secretion system to kill biofilm-associated amoebae, ISME J, vol.2, pp.843-852, 2008.

S. Mion, L. Plener, B. Rémy, D. Daudé, C. et al., Lactonase SsoPox modulates CRISPR-Cas expression in gram-negative proteobacteria using AHL-based quorum sensing systems, Res. Microbiol, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02454491

S. Mion, B. Rémy, L. Plener, E. Chabrière, and D. Daudé, Empêcher les bactéries de communiquer: diviser pour mieux soigner, Ann. Pharm. Fr, vol.76, pp.249-264, 2018.

A. Price-whelan, L. E. Dietrich, and D. K. Newman, Pyocyanin alters redox homeostasis and carbon flux through central metabolic pathways in Pseudomonas aeruginosa PA14, J. Bacteriol, vol.189, pp.6372-6381, 2007.

X. Qin, Q. Sun, B. Yang, X. Pan, Y. He et al., Quorum sensing influences phage infection efficiency via affecting cell population and physiological state, J. Basic Microbiol, vol.57, pp.162-170, 2017.

B. Rémy, S. Mion, L. Plener, M. Elias, E. Chabrière et al., Interference in bacterial quorum sensing: a biopharmaceutical perspective, Front. Pharmacol, vol.9, p.203, 2018.

B. Rémy, L. Plener, L. Poirier, M. Elias, D. Daudé et al., Harnessing hyperthermostable lactonase from Sulfolobus solfataricus for biotechnological applications, Sci. Rep, vol.6, p.37780, 2016.

D. D. Rhoads, R. D. Wolcott, M. A. Kuskowski, B. M. Wolcott, L. S. Ward et al., Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial, J. Wound Care, vol.18, pp.237-243, 2009.

J. Rolain, S. Hraiech, and F. Bregeon, Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status, Drug Des. Devel. Ther, vol.9, pp.3653-3663, 2015.

G. P. Salmond and P. C. Fineran, A century of the phage: past, present and future, Nat. Rev. Microbiol, vol.13, pp.777-786, 2015.

M. A. Saucedo-mora, P. Castañeda-tamez, A. Cazares, J. Pérez-velázquez, B. A. Hense et al., Selection of functional quorum sensing systems by lysogenic bacteriophages in Pseudomonas aeruginosa, Front. Microbiol, vol.8, p.1669, 2017.

K. M. Smith, Y. Bu, and H. Suga, Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs, Chem. Biol, vol.10, pp.81-89, 2003.

A. D. Soyza, A. J. Hall, E. Mahenthiralingam, P. Drevinek, W. Kaca et al., Developing an international Pseudomonas aeruginosa reference panel, vol.2, pp.1010-1023, 2013.

S. Stepanovi?, D. Vukovi?, I. Daki?, B. Savi?, and M. ?vabi?-vlahovi?, A modified microtiter-plate test for quantification of staphylococcal biofilm formation, J. Microbiol. Methods, vol.40, pp.122-128, 2000.

C. A. Suttle, Viruses in the sea, Nature, vol.437, p.356, 2005.

E. Tacconelli, E. Carrara, A. Savoldi, S. Harbarth, M. Mendelson et al., Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis, Lancet Infect. Dis, vol.18, pp.318-327, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02347423

M. A. Welsh and H. E. Blackwell, Chemical genetics reveals environmentspecific roles for quorum sensing circuits in Pseudomonas aeruginosa, Cell Chem. Biol, vol.23, pp.361-369, 2016.

A. Wright, C. H. Hawkins, E. E. Änggård, and D. R. Harper, A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy, Clin. Otolaryngol, vol.34, pp.349-357, 2009.